Astrazeneca plc (A1ZN34)
BOV
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10.98B | 11.21B | 10.88B | 11.42B | 11.49B | 12.02B | 12.68B | 12.94B |
Operating Income | 1.16B | 1.08B | 2.3B | 2.7B | 1.7B | 1.23B | 3.1B | 2.72B |
Pre Tax Income | 923M | 778M | 2.26B | 2.09B | 1.65B | 897M | 2.8B | 2.4B |
Net Income | 1.64B | 901M | 1.8B | 1.82B | 1.37B | 960M | 2.18B | 1.93B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 1.25B | 1.09B | 2.55B | 2.7B | 1.94B | 1.23B | 3.1B | 2.74B |
EBITDA | -1.5B | 6.55B | 3.8B | 3.98B | 2.98B | 2.56B | 4.36B | 4B |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 23B | 22.47B | 22.09B | 24.38B | 26.62B | 37.42B | 44.35B | 45.81B |
Operating Income | 3.68B | 2.09B | 1.4B | 1.59B | 4.08B | -293M | 3.54B | 7.89B |
Pre Tax Income | 3.55B | 2.23B | 1.99B | 1.55B | 3.92B | -265M | 2.5B | 6.9B |
Net Income | 3.5B | 3B | 2.16B | 1.34B | 3.2B | 112M | 3.29B | 5.96B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 2.766 | 2.37 | 1.701 | 1.017 | 2.435 | 0.072 | 2.122 | 3.842 |
EBIT | 4.87B | 3.46B | 3.27B | 2.81B | 5.14B | 216M | 3.75B | 8.18B |
EBITDA | 6.04B | 5.11B | 5.15B | 5.35B | 7.23B | 6.24B | 9.02B | 13.28B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.